Agentic AI Systems represent a significant ad-vancement in artificial intelligence by enabling systems to autonomously perceive, decide, and act in complex environments. This review explores the definition, scope, advantages, challenges, opportunities, and trustworthiness of agentic AI in organizational and societal contexts. Agentic AI offers higher efficiency, scalability, and improved decision making which enables the organizations to streamline operations and enhance their productivity. Despite these advancements Agentic AI has its own challenges such as; safety concerns, accountability, reliability issues and potential misuse remain critical areas for consideration. This paper provides a comprehensive discussion of agentic AI's impact in emphasizing both its transformative potential and the need for continuous oversight and refinement.
AI-enabled secure electronic informed consent (eConsent) tools are increasingly adopted in clinical trials to enhance patient awareness, accelerate participant recruitment, and enable remote access to research studies. These systems integrate advanced technologies such as audit trails, encryption, identity verification, and blockchain-based dynamic consent mechanisms to ensure transparency, security, and trust. The framework emphasizes compliance with critical regulatory and ethical standards, including HIPAA, GDPR, and ICH-GCP, to protect participant data privacy and maintain data integrity throughout the consent lifecycle. This work analyzes major security threats to eConsent systems, particularly data breaches and authentication vulnerabilities and discusses effective mitigation strategies. Electronic informed consent exemplifies how digital transformation is reshaping clinical research, as eConsent platforms improve participant understanding, engagement, and oversight. Consequently, AI-enabled eConsent systems are progressively replacing traditional paper-based consent processes in modern clinical trials.